The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Platelet GP IIIa Pl A Polymorphisms Display Different Sensitivities to Agonists
Abstract
Background —Both inherited predisposition and platelet hyperreactivity have been associated with ischemic coronary events, but mechanisms that support genetic differences among platelets from different subjects are generally lacking. Associations between the platelet Pl A2 polymorphism of GP IIIa and coronary syndromes raise the question as to whether this inherited variation may contribute to platelet hyperreactivity. Methods and Results —In this study, we characterized functional parameters in platelets from healthy donors with the Pl A (HPA-1) polymorphism, a Leu (Pl A1 ) to Pro (Pl A2 ) substitution at position 33 of the GP IIIa subunit of the platelet GP IIb/IIIa receptor (integrin α IIb β 3 ). We studied 56 normal donors (20 Pl A1,A1 , 20 Pl A1,A2 , and 16 Pl A2,A2 ). Compared with Pl A1,A1 platelets, Pl A2 -positive platelets showed a gene dosage effect for significantly greater surface-expressed P-selectin, GP IIb/IIIa–bound fibrinogen, and activated GP IIb/IIIa in response to low-dose ADP. Surface expression of GP IIb/IIIa was similar in resting platelets of all 3 genotypes but was significantly greater on Pl A2,A2 platelets after ADP stimulation ( P =0.003 versus Pl A1,A1 ; P =0.03 versus Pl A1,A2 ). Pl A1,A2 platelets were more sensitive to inhibition of aggregation by pharmacologically relevant concentrations of aspirin and abciximab. Conclusions —Pl A2 -positive platelets displayed a lower threshold for activation, and platelets heterozygous for Pl A alleles showed increased sensitivity to 2 antiplatelet drugs. These in vitro platelet studies may have relevance for in vivo thrombotic conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)
Fuster, V. (1992) · New England Journal of Medicine · Cited by 1,954
Stenberg, P. E., McEver, R. P., Shuman, M. A., Jacques, Y. V., & Bainton, D. F. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.880 · Cited by 871
Weiss, E. J., Bray, P. F., Tayback, M., Schulman, S. P., Kickler, T. S., Becker, L. C., Weiss, J. L., Gerstenblith, G., & Goldschmidt-Clermont, P. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341703 · Cited by 689
Self-citationIntegrin Signaling: The Platelet Paradigm
Shattil, S. J., Kashiwagi, H., & Pampori, N. (1998) · Blood · doi:10.1182/blood.v91.8.2645.2645_2645_2657 · Cited by 665
Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction
Trip, M. D., Cats, V. M., van Capelle, F. J. L., & Vreeken, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222201 · Cited by 617
Kinetics of pharmacologic response
Holford, N. H. G., & Sheiner, L. B. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90051-1 · Cited by 501
Flow cytometry: a clinical test of platelet function
Michelson, A. (1996) · Blood · doi:10.1182/blood.v87.12.4925.bloodjournal87124925 · Cited by 490
Self-citationAnalysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets
Wagner, C., Mascelli, M., Neblock, D., Weisman, H., Coller, B., & Jordan, R. (1996) · Blood · doi:10.1182/blood.v88.3.907.907 · Cited by 460
Self-citation
Cited by
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M.-L. T., Schmittgen, T. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003694 · Cited by 1,452
Scientific and therapeutic advances in antiplatelet therapy
Bhatt, D. L., & Topol, E. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd985 · Cited by 407
Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions
Undas, A., Brummel-Ziedins, K. E., & Mann, K. G. (2007) · Blood · doi:10.1182/blood-2006-01-010645 · Cited by 254
Diagnosis and Treatment of Heart Disease: Are Women Different From Men?
Xhyheri, B., & Bugiardini, R. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.07.004 · Cited by 56
Metadata
- Authors
- Michelson, A. D., Furman, M. I., Goldschmidt-Clermont, P., Mascelli, M. A., Hendrix, C., Coleman, L., Hamlington, J., Barnard, M. R., Kickler, T., Christie, D. J., Kundu, S., & Bray, P. F.
- Venue
- Circulation
- Published
- 2000-03-07
- Volume
- 101
- Issue
- 9
- Pages
- 1013-1018
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2033476357
- Cited by
- 310
- References
- 18
- FWCI
- 14.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Platelet GP IIIa Pl A Polymorphisms Display Different Sensitivities to Agonists. https://app.cochat.ai/papers/10.1161/01.cir.101.9.1013
- The paper
- Michelson, A. D., Furman, M. I., Goldschmidt-Clermont, P., Mascelli, M. A., Hendrix, C., Coleman, L., Hamlington, J., Barnard, M. R., Kickler, T., Christie, D. J., Kundu, S., & Bray, P. F. (2000). Platelet GP IIIa Pl A Polymorphisms Display Different Sensitivities to Agonists. Circulation. https://doi.org/10.1161/01.cir.101.9.1013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.